Bruntwood SciTech has received the go-ahead for a £60m redevelopment of Manchester Science Park’s Greenheys building.
It will be transformed into a 6-storey purpose-built development designed specifically for scaling life science businesses working in diagnostics, genomics, biotech and precision medicine.
The development will also be home to UK Biobank, which is moving from Stockport, as announced earlier this year.
“We are pleased to have had approval on our plans for the redevelopment of Greenheys which will see it become one of the most advanced and specialist life science spaces in the UK,” said Peter Crowther, Property Director at Bruntwood SciTech.
“With UK Biobank already announced to move to the new hub, we know this will be a big draw for scaling life science businesses who are keen to be located in the same building and access opportunities to work together with both them and the neighbouring researchers at The University of Manchester. The new Greenheys will build on the North West’s world-leading cluster of clinical, academic and commercial assets and we look forward to commencing with our enabling works later this summer and construction early next year.”
There will be specialist design features incorporated into the building including increased vibration resistance and floor loading, the provision of piped gas distribution systems, enhanced cooling and ventilation systems, Local Exhaust Ventilation servicing to facilitate fume cupboard installations, high security access and 100GB superfast connectivity.
It’s expected to open in Spring 2026 and is part of a wider masterplan to grow the science and technology hub to 1m sq ft.
Bruntwood SciTech is a 50:50 joint venture between Bruntwood and Legal & General.
